Immunotherapy for Advanced Skin Cancer in Kidney Transplant Recipients-The High-Risk Balancing Act

JAMA Dermatol. 2024 Aug 1;160(8):799-800. doi: 10.1001/jamadermatol.2024.2109.

Authors

Madeliene Stump^{1

2}, Sarah Arron³, Charlotte Proby⁴

Affiliations

¹ Department of Dermatology, Johns Hopkins School of Medicine, Baltimore, Maryland.
² now with Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
³ Peninsula Dermatology, Burlingame, California.
⁴ Department of Dermatology, Division of Molecular and Clinical Medicine, Ninewells Hospital & Medical School, University of Dundee, Dundee, United Kingdom.

PMID: 38985483
DOI: 10.1001/jamadermatol.2024.2109

No abstract available

Plain language summary

This Viewpoint compares 2 clinical trials involving immune checkpoint inhibitors in kidney transplant recipients.

MeSH terms

Humans
Immunotherapy / methods
Kidney Transplantation*
Skin Neoplasms* / pathology
Transplant Recipients / statistics & numerical data